Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression. - Abenavoli L; Loricchio AG; Lopez I; Morano D; Ismaiel A; Dumitrascu DL; Luzza F (Medicina (Kaunas, Lithuania), 2026)